These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 7556412)

  • 1. Cyclosporin A is a substance P (tachykinin NK1) receptor antagonist.
    Gitter BD; Waters DC; Threlkeld PG; Lovelace AM; Matsumoto K; Bruns RF
    Eur J Pharmacol; 1995 May; 289(3):439-46. PubMed ID: 7556412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of both NK1 and NK2 receptors in guinea-pig airways.
    McKee KT; Millar L; Rodger IW; Metters KM
    Br J Pharmacol; 1993 Oct; 110(2):693-700. PubMed ID: 7694756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
    Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
    Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
    Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
    Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of [125I][MePhe7]neurokinin B binding to tachykinin NK3 receptors: evidence for interspecies variance.
    Suman-Chauhan N; Grimson P; Guard S; Madden Z; Chung FZ; Watling K; Pinnock R; Woodruff G
    Eur J Pharmacol; 1994 Sep; 269(1):65-72. PubMed ID: 7530207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
    Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A
    Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
    Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
    J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiographic localization of tachykinin NK2 and NK1 receptors in the guinea-pig lung, using selective radioligands.
    Strigas J; Burcher E
    Eur J Pharmacol; 1996 Sep; 311(2-3):177-86. PubMed ID: 8891598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
    Cheng FH; Chan SW; Rudd JA
    Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
    Emonds-Alt X; Proietto V; Steinberg R; Oury-Donat F; Vigé X; Vilain P; Naline E; Daoui S; Advenier C; Le Fur G; Maffrand JP; Soubrié P; Pascal M
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1171-9. PubMed ID: 12438541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
    Patacchini R; Quartara L; Rolka K; Zboinska J; Kupryszewski G; Maggi CA
    Eur J Pharmacol; 1993 Dec; 250(2):311-6. PubMed ID: 7509285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the distribution and characteristics of tachykinin NK1 binding sites between human and guinea pig lung.
    Walsh DA; Salmon M; Featherstone R; Wharton J; Church MK; Polak JM
    Br J Pharmacol; 1994 Dec; 113(4):1407-15. PubMed ID: 7534186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.
    Floch A; Fardin V; Cavero I
    Br J Pharmacol; 1994 Mar; 111(3):759-68. PubMed ID: 7517328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of tachykinin NK3 receptor-mediated colonic ion transport in the guinea pig.
    Goldhill J; Angel I
    Eur J Pharmacol; 1998 Dec; 363(2-3):161-8. PubMed ID: 9881585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.
    Beattie DT; Beresford IJ; Connor HE; Marshall FH; Hawcock AB; Hagan RM; Bowers J; Birch PJ; Ward P
    Br J Pharmacol; 1995 Dec; 116(8):3149-57. PubMed ID: 8719789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
    Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new selective bioassay for tachykinin NK3 receptors based on inositol monophosphate accumulation in the guinea pig ileum.
    Petitet F; Saffroy M; Torrens Y; Glowinski J; Beaujouan JC
    Eur J Pharmacol; 1993 Oct; 247(2):185-91. PubMed ID: 7506659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
    Anthes JC; Chapman RW; Richard C; Eckel S; Corboz M; Hey JA; Fernandez X; Greenfeder S; McLeod R; Sehring S; Rizzo C; Crawley Y; Shih NY; Piwinski J; Reichard G; Ting P; Carruthers N; Cuss FM; Billah M; Kreutner W; Egan RW
    Eur J Pharmacol; 2002 Aug; 450(2):191-202. PubMed ID: 12206858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK1 and NK2 receptor antagonist.
    Robineau P; Lonchampt M; Kucharczyk N; Krause JE; Regoli D; Fauchere JL; Prost JF; Canet E
    Eur J Pharmacol; 1995 Dec; 294(2-3):677-84. PubMed ID: 8750733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801.
    Beaujouan JC; Saffroy M; Torrens Y; Glowinski J
    Eur J Pharmacol; 1997 Jan; 319(2-3):307-16. PubMed ID: 9042606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.